Kissei Pharmaceutical Future Growth
Future criteria checks 0/6
Kissei Pharmaceutical's earnings are forecast to decline at 5.3% per annum while its annual revenue is expected to grow at 3.6% per year. EPS is expected to decline by 4.9% per annum. Return on equity is forecast to be 3.8% in 3 years.
Key information
-5.3%
Earnings growth rate
-4.9%
EPS growth rate
Pharmaceuticals earnings growth | 23.9% |
Revenue growth rate | 3.6% |
Future return on equity | 3.8% |
Analyst coverage | Low |
Last updated | 05 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 89,364 | 8,057 | 8,414 | 8,185 | 3 |
3/31/2026 | 85,449 | 9,067 | 11,712 | 8,620 | 3 |
3/31/2025 | 84,700 | 11,967 | 5,031 | 1,707 | 2 |
9/30/2024 | 81,067 | 10,731 | 291 | 3,431 | N/A |
6/30/2024 | 77,430 | 12,001 | N/A | N/A | N/A |
3/31/2024 | 75,579 | 11,160 | -3,510 | -1,677 | N/A |
12/31/2023 | 73,717 | 12,198 | N/A | N/A | N/A |
9/30/2023 | 71,607 | 12,880 | -8,350 | -5,854 | N/A |
6/30/2023 | 70,521 | 12,158 | N/A | N/A | N/A |
3/31/2023 | 67,493 | 10,528 | -9,226 | -6,679 | N/A |
12/31/2022 | 66,931 | 12,769 | N/A | N/A | N/A |
9/30/2022 | 65,857 | 10,581 | -4,543 | -2,556 | N/A |
6/30/2022 | 65,031 | 10,912 | N/A | N/A | N/A |
3/31/2022 | 65,381 | 12,921 | -386 | 1,533 | N/A |
12/31/2021 | 66,934 | 5,664 | N/A | N/A | N/A |
9/30/2021 | 69,148 | 6,555 | -2,042 | -349 | N/A |
6/30/2021 | 69,618 | 7,204 | N/A | N/A | N/A |
3/31/2021 | 69,044 | 5,285 | -4,027 | -2,542 | N/A |
12/31/2020 | 66,877 | 5,715 | N/A | N/A | N/A |
9/30/2020 | 63,970 | 5,063 | -573 | 683 | N/A |
6/30/2020 | 63,196 | 2,530 | N/A | N/A | N/A |
3/31/2020 | 63,234 | 2,817 | 12,632 | 13,934 | N/A |
12/31/2019 | 65,594 | 4,753 | N/A | N/A | N/A |
9/30/2019 | 68,180 | 4,294 | 9,189 | 10,431 | N/A |
6/30/2019 | 70,545 | 4,752 | N/A | N/A | N/A |
3/31/2019 | 72,297 | 5,481 | 5,013 | 6,346 | N/A |
12/31/2018 | 72,474 | 5,263 | N/A | N/A | N/A |
9/30/2018 | 73,087 | 8,102 | 12,159 | 13,854 | N/A |
6/30/2018 | 73,014 | 9,685 | N/A | N/A | N/A |
3/31/2018 | 74,009 | 9,045 | N/A | 8,845 | N/A |
12/31/2017 | 73,887 | 8,735 | N/A | N/A | N/A |
9/30/2017 | 72,459 | 8,116 | N/A | 5,756 | N/A |
6/30/2017 | 71,396 | 6,993 | N/A | N/A | N/A |
3/31/2017 | 71,706 | 7,726 | N/A | 6,441 | N/A |
12/31/2016 | 72,154 | 6,401 | N/A | N/A | N/A |
9/30/2016 | 73,533 | 8,108 | N/A | 9,023 | N/A |
6/30/2016 | 73,774 | 8,734 | N/A | N/A | N/A |
3/31/2016 | 71,294 | 8,165 | N/A | 5,763 | N/A |
12/31/2015 | 71,239 | 8,521 | N/A | N/A | N/A |
9/30/2015 | 69,095 | 6,608 | N/A | 2,948 | N/A |
6/30/2015 | 70,945 | 7,161 | N/A | N/A | N/A |
3/31/2015 | 70,110 | 7,165 | N/A | 6,667 | N/A |
12/31/2014 | 69,666 | 7,829 | N/A | N/A | N/A |
9/30/2014 | 73,090 | 9,817 | N/A | 9,538 | N/A |
6/30/2014 | 69,934 | 8,935 | N/A | N/A | N/A |
3/31/2014 | 70,399 | 9,093 | N/A | 11,945 | N/A |
12/31/2013 | 69,335 | 9,365 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KSPH.F's earnings are forecast to decline over the next 3 years (-5.3% per year).
Earnings vs Market: KSPH.F's earnings are forecast to decline over the next 3 years (-5.3% per year).
High Growth Earnings: KSPH.F's earnings are forecast to decline over the next 3 years.
Revenue vs Market: KSPH.F's revenue (3.6% per year) is forecast to grow slower than the US market (8.9% per year).
High Growth Revenue: KSPH.F's revenue (3.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: KSPH.F's Return on Equity is forecast to be low in 3 years time (3.8%).